Business
Director Dealing
Director Dealing.
About this update from Proteome Sciences Plc
[{"type":"text","content":"\n \nRNS Number : 8452K Proteome Sciences PLC 05 January 2016 \n\n \n \nPRESS RELEASE\n \n 5 January 2016\n \nProteome Sciences plc\n(\"Proteome Sciences\" or the \"Company\")\n \nDirector Dealing\n \nThe Company has received notification from Vulpes Life Sciences Fund (\"Vulpes\") that it has a total direct and indirect interest in 36,573,125 ordinary shares of 1p each in the capital of the Company (\"Ordinary Shares\") equivalent to 16.04% of Proteome Sciences' total issued share capital. The Company would also like to announce that by virtue of Martin Diggle being a Director of both Vulpes and the Company, he now has an interest in 36,573,125 Ordinary Shares of the Company representing 16.04% of the issued share capital of the Company. \n \nFor further information please contact: \n \n\n\n\n\nProteome Sciences plc \n\n\n\n\nChristopher Pearce, Chief Executive Officer \n\n\n\n\n\n\n\nIan Pike, Chief Operating Officer\n\n\nTel: +44 (0)1932 865065\n\n\n\n\nGeoff Ellis, Finance Director\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nfinnCap Limited (Nominated adviser & broker)\n\n\n\n\nGeoff Nash/James Thompson \n\n\nTel: +44 (0)20 7220 0500\n \n\n\n\n\nPublic Relations \n\n\n\n\nIKON Associates \n\n\n\n\n\n\n\nAdrian Shaw \n\n\nEmail: [email protected]\n\n\n\n\nTel: +44 (0)1483 271291\nMob: +44 (0)797 9900733\n\n\nTel: +44 (0)1483 271291\nMob: +44 (0)7979 900733\n\n\n\n\n \n \n \nNotes to Editors:\n \nAbout Proteome Sciences plc (www.proteomics.com)\nWith its HQ in Cobham, U...